Optimization of theophylline sustained release tablet formula with HPMC, CMC Na and xanthan gum as matrix component

Agus Siswanto, Sri Sulihtyowati Soebagyo


Theophylline has a relatively short half-life (8,1 jam) with a narrow therapeutic window (10 – 20 μg/mL). Sustained-release formulation can produce more uniform serum concentrations with less fluctuation in peaktrough levels. The physical properties of tablet mass and the release profile

of drug from hydrophilic matrices are influenced by properties of matrix components, i.e. HPMC (gelling agent), CMC-Na (did not show initial burst release), and xanthan gum (free flowing).

The research was done with simplex lattice design (SLD) by using 3 component, i.e. HPMC (A), CMC-Na (B), and xanthan gum (C). Seven formula were obtained that are F1 (100% A), F2 (100% B), F3 (100% C), F4 (50% A & 50% B), F5 (50% B & 50% C), F6 (50% A & 50% C), dan F7 (33,33% A, 33,33% B, 33,33% C). The Optimization parameters of theophylline sustained-release were flow rate of the tablet mass, the compactibility of the tablet mass, and the release rate of theophylline.Based on SLD model; equations, contour plots, and superimposed of contour plots were obtained, by which the optimum formula was determined.

Xanthan gum was the most dominant factor in increasing flowability and compactibility of theophylline tablet mass. HPMC was the most dominant factor in decreasing the dissolution rate of theophylline. The most dominant interaction effect to increase flowability and compactibility was the interaction of HPMC, CMC-Na, and xanthan gum. The most dominant interaction effect to increase correlation coefficient of zero order kinetics was the interaction HPMC and CMC-Na. Based on the superimposed contour plots, tablet formula consisting of HPMC (2,3 %), CMC-Na (18,6 %), and xanthan gum (79,1 %) is the optimum tablet formula.

Key words: theophylline, HPMC, CMC-Na, xanthan gum, sustained-release

Full Text:



Anonim, 1995, Farmakope Indonesia, Ed. IV, Departemen Kesehatan Republik Indonesia, Jakarta, 783 – 784, 175.

Bayomi, M.A., Al-Suwayeh, S.A., and El-Helw, A.M., 2001, Excipient-Excipient Interaction in the Design of Sustained-Release Theophylline Tablets: In Vitro and In Vivo Evaluation, Drug Dev. Ind. Pharm., 27(6), 499 – 506.

Bhardwaj, T.R., Kanwar, M., Lal, R., and Gupta, A., 2000, Natural Gums and Modified Gums as Sustained-Release Carriers, Drug Dev. Ind. Pharm., 26(10), 1025 – 1038 .

Bolhuis, G.K., and Chowhan, Z.T., 1996, Material for Direct Compaction, in Alderborn, G., and Nystrom, C., Pharmaceutical Powder Compaction Technology, Marcel Dekker Inc., New York, 438 – 439.

Emami, J., and Tavakoli, N., 2004, Formulation of Sustained-Release Lithium Carbonate Matrix Tablets: Influent of Hydrophilic Material on The Release Rate and In Vitro-In Vivo Evaluation, J Pharm Pharmaceut Sci, 7(3) ,338-344.

Fudholi, A., 1983, Metodologi Formulasi Dalam Kompresi Direk, Medika, 7(9), 586 – 593 .

Gordon, R.E., Rosanke, T.W., Fonner, D.E., Anderson, N.R., and Banker, G.S., 1990, Granulation Technology and Tablet Characterization, in Lieberman, H.A., Lachman, L., Schwartz, J.B., Pharmaceutical Dosage Form: Tablet, 2nd Ed., Revised and Expanded vol 2, Marcel Dekker Inc., New York, 327 – 332.

Parfitt, K., 1999, Martindale The Complete Drug Reference, 32nd Ed., Pharmaceutical Press, London, 765 – 773, 1471 – 1475.

DOI: http://dx.doi.org/10.14499/indonesianjpharm0iss0pp143-148


  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Indonesian J Pharm indexed by:

analytics View My Stats